Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123057363 | 12305736 | 3 | F | 2009 | 20160701 | 20160426 | 20160708 | EXP | BR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-25316BR | BOEHRINGER INGELHEIM | 58.45 | YR | F | Y | 50.00000 | KG | 20160708 | MD | COUNTRY NOT SPECIFIED | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123057363 | 12305736 | 1 | PS | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | Respiratory (inhalation) | 7.5 MCG | 21936 | 2.5 | UG | PRESSURISED INHALATION | TID | ||||||
| 123057363 | 12305736 | 2 | C | SERETIDE | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | 500 MG | 0 | 250 | MG | CUTANEOUS POWDER | BID | ||||||
| 123057363 | 12305736 | 3 | C | CLENIL | BECLOMETHASONE DIPROPIONATE | 1 | Respiratory (inhalation) | 250 MG | 0 | 250 | MG | QD | |||||||
| 123057363 | 12305736 | 4 | C | FLUIR | FORMOTEROL FUMARATE | 1 | Respiratory (inhalation) | 48 MG | 0 | 12 | MG | CUTANEOUS POWDER | QID | ||||||
| 123057363 | 12305736 | 5 | C | INFLUENZA VACCINE | INFLUENZA VIRUS VACCINE | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123057363 | 12305736 | 1 | Chronic obstructive pulmonary disease |
| 123057363 | 12305736 | 2 | Chronic obstructive pulmonary disease |
| 123057363 | 12305736 | 3 | Chronic obstructive pulmonary disease |
| 123057363 | 12305736 | 4 | Chronic obstructive pulmonary disease |
| 123057363 | 12305736 | 5 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123057363 | 12305736 | OT |
| 123057363 | 12305736 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123057363 | 12305736 | Asthma | |
| 123057363 | 12305736 | Dizziness | |
| 123057363 | 12305736 | Dyspnoea | |
| 123057363 | 12305736 | Haemoptysis | |
| 123057363 | 12305736 | Oropharyngeal pain | |
| 123057363 | 12305736 | Overdose | |
| 123057363 | 12305736 | Pneumonia | |
| 123057363 | 12305736 | Pneumonitis | |
| 123057363 | 12305736 | Pulmonary mass | |
| 123057363 | 12305736 | Pulmonary pain | |
| 123057363 | 12305736 | Stomatitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123057363 | 12305736 | 1 | 2009 | 0 | ||
| 123057363 | 12305736 | 2 | 2009 | 0 | ||
| 123057363 | 12305736 | 3 | 2009 | 0 | ||
| 123057363 | 12305736 | 4 | 2009 | 0 | ||
| 123057363 | 12305736 | 5 | 20160518 | 20160518 | 0 |